{"id":"https://openalex.org/W2092025577","doi":"https://doi.org/10.1097/00007691-200406000-00018","title":"Ritonavir Decreases the Nonrenal Clearance of Digoxin in Healthy Volunteers with Known MDR1 Genotypes","display_name":"Ritonavir Decreases the Nonrenal Clearance of Digoxin in Healthy Volunteers with Known MDR1 Genotypes","publication_year":2004,"publication_date":"2004-05-21","ids":{"openalex":"https://openalex.org/W2092025577","doi":"https://doi.org/10.1097/00007691-200406000-00018","mag":"2092025577","pmid":"https://pubmed.ncbi.nlm.nih.gov/15167636"},"language":"en","primary_location":{"id":"doi:10.1097/00007691-200406000-00018","doi":"https://doi.org/10.1097/00007691-200406000-00018","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00007691-200406000-00018","pdf_url":null,"source":{"id":"https://openalex.org/S179268941","display_name":"Therapeutic Drug Monitoring","issn_l":"0163-4356","issn":["0163-4356","1536-3694"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic Drug Monitoring","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5019363661","display_name":"Scott R Penzak","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210155647","display_name":"National Institutes of Health Clinical Center","ror":"https://ror.org/04vfsmv21","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210155647"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Scott R. Penzak","raw_affiliation_strings":["Warren G. Magnuson Clinical Center, Pharmacy Department, National Institutes of Health, Bethesda, Maryland 20892, USA","Warren G. Magnuson Clinical Center, Pharmacy Department, National Institutes of Health, Bethesda, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Warren G. Magnuson Clinical Center, Pharmacy Department, National Institutes of Health, Bethesda, Maryland 20892, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210155647"]},{"raw_affiliation_string":"Warren G. Magnuson Clinical Center, Pharmacy Department, National Institutes of Health, Bethesda, Maryland","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210155647"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040279151","display_name":"Jean Shen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210134534","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210134534"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jean M. Shen","raw_affiliation_strings":["National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210134534"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108519886","display_name":"Raul M. Alfaro","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210155647","display_name":"National Institutes of Health Clinical Center","ror":"https://ror.org/04vfsmv21","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210155647"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Raul M. Alfaro","raw_affiliation_strings":["Warren G. Magnuson Clinical Center, Pharmacy Department, National Institutes of Health, Bethesda, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Warren G. Magnuson Clinical Center, Pharmacy Department, National Institutes of Health, Bethesda, Maryland","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210155647"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068951391","display_name":"Alan Thomas Remaley","orcid":"https://orcid.org/0000-0003-2473-5549","observed_orcids":["https://orcid.org/0000-0003-2473-5549","https://orcid.org/0000-0001-5839-7280"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210155647","display_name":"National Institutes of Health Clinical Center","ror":"https://ror.org/04vfsmv21","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210155647"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alan T. Remaley","raw_affiliation_strings":["Warren G. Magnuson Clinical Center, Department of Laboratory Medicine, National Institutes of Health, Bethesda, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Warren G. Magnuson Clinical Center, Department of Laboratory Medicine, National Institutes of Health, Bethesda, Maryland","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210155647"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110658888","display_name":"Ven Natarajan","orcid":"https://orcid.org/0000-0002-2536-5351","observed_orcids":["https://orcid.org/0000-0002-2536-5351"]},"institutions":[{"id":"https://openalex.org/I880747138","display_name":"Science Applications International Corporation (United States)","ror":"https://ror.org/00zv91802","country_code":"US","type":"company","lineage":["https://openalex.org/I880747138"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ven Natarajan","raw_affiliation_strings":["Science Applications International Corporation-Frederick, Inc, Frederick, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Science Applications International Corporation-Frederick, Inc, Frederick, Maryland","institution_ids":["https://openalex.org/I880747138"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5009813178","display_name":"Judith Falloon","orcid":"https://orcid.org/0000-0002-6298-8953","observed_orcids":["https://orcid.org/0000-0002-6298-8953"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210134534","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210134534"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Judith Falloon","raw_affiliation_strings":["National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210134534"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5019363661","https://openalex.org/A5108519886"],"corresponding_institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210155647"],"apc_list":null,"apc_paid":null,"fwci":2.8787,"has_fulltext":false,"cited_by_count":62,"citation_normalized_percentile":{"value":0.90637223,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"26","issue":"3","first_page":"322","last_page":"330"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.5659000277519226,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.5659000277519226,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.4309000074863434,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10496","display_name":"Pharmaceutical Practices and Patient Outcomes","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2717","display_name":"Geriatrics and Gerontology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ritonavir","display_name":"ritonavir","score":1.0},{"id":"https://openalex.org/keywords/digoxin","display_name":"digoxin","score":0.9980000257492065},{"id":"https://openalex.org/keywords/p-glycoprotein","display_name":"P-glycoprotein","score":0.9819999933242798},{"id":"https://openalex.org/keywords/mdr1-gene-polymorphism","display_name":"MDR1 gene polymorphism","score":0.7929999828338623},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.8700000047683716},{"id":"https://openalex.org/keywords/nonrenal-clearance","display_name":"nonrenal clearance","score":0.7200000286102295},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8140000104904175},{"id":"https://openalex.org/keywords/drug-transport-inhibition","display_name":"drug transport inhibition","score":0.4099999964237213},{"id":"https://openalex.org/keywords/healthy-volunteers","display_name":"healthy volunteers","score":0.5979999899864197}],"concepts":[{"id":"https://openalex.org/C2779298103","wikidata":"https://www.wikidata.org/wiki/Q422618","display_name":"Ritonavir","level":5,"score":0.9016203284263611},{"id":"https://openalex.org/C2777707475","wikidata":"https://www.wikidata.org/wiki/Q422222","display_name":"Digoxin","level":3,"score":0.8890113234519958},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.8343423008918762},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6521583199501038},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4732516407966614},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3375239670276642},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.32146063446998596},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.13446789979934692},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.12861427664756775},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.10227441787719727},{"id":"https://openalex.org/C2778198053","wikidata":"https://www.wikidata.org/wiki/Q181754","display_name":"Heart failure","level":2,"score":0.07083651423454285},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.05170854926109314}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004077","descriptor_name":"Digoxin","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D004077","descriptor_name":"Digoxin","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D004077","descriptor_name":"Digoxin","qualifier_ui":"Q000652","qualifier_name":"urine","is_major_topic":false},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005838","descriptor_name":"Genotype","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008657","descriptor_name":"Metabolic Clearance Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010349","descriptor_name":"Patient Compliance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016133","descriptor_name":"Polymerase Chain Reaction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017320","descriptor_name":"HIV Protease Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D017320","descriptor_name":"HIV Protease Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D019438","descriptor_name":"Ritonavir","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D019438","descriptor_name":"Ritonavir","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D019450","descriptor_name":"Genes, MDR","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020168","descriptor_name":"ATP Binding Cassette Transporter, Subfamily B, Member 1","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D020168","descriptor_name":"ATP Binding Cassette Transporter, Subfamily B, Member 1","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/00007691-200406000-00018","doi":"https://doi.org/10.1097/00007691-200406000-00018","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00007691-200406000-00018","pdf_url":null,"source":{"id":"https://openalex.org/S179268941","display_name":"Therapeutic Drug Monitoring","issn_l":"0163-4356","issn":["0163-4356","1536-3694"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic Drug Monitoring","raw_type":"journal-article"},{"id":"pmid:15167636","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15167636","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic drug monitoring","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[{"id":"https://openalex.org/G1356092923","display_name":null,"funder_award_id":"N01CO12400","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G174812244","display_name":"DCTD Computer Support","funder_award_id":"n01co12400-79-0-22","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":44,"referenced_works":["https://openalex.org/W113805164","https://openalex.org/W1797316917","https://openalex.org/W1974606231","https://openalex.org/W1975396712","https://openalex.org/W1977073394","https://openalex.org/W1991797788","https://openalex.org/W1997635642","https://openalex.org/W2008077160","https://openalex.org/W2010562714","https://openalex.org/W2012657157","https://openalex.org/W2013047801","https://openalex.org/W2021506803","https://openalex.org/W2022274978","https://openalex.org/W2022470615","https://openalex.org/W2025233096","https://openalex.org/W2029096206","https://openalex.org/W2030449390","https://openalex.org/W2031595392","https://openalex.org/W2034141345","https://openalex.org/W2034618224","https://openalex.org/W2054458932","https://openalex.org/W2058344808","https://openalex.org/W2065508314","https://openalex.org/W2067274937","https://openalex.org/W2078440790","https://openalex.org/W2078877172","https://openalex.org/W2084152024","https://openalex.org/W2092118786","https://openalex.org/W2101610746","https://openalex.org/W2110886272","https://openalex.org/W2116343321","https://openalex.org/W2118234018","https://openalex.org/W2118342649","https://openalex.org/W2121167726","https://openalex.org/W2125615173","https://openalex.org/W2131403498","https://openalex.org/W2141791066","https://openalex.org/W2158246924","https://openalex.org/W2168540099","https://openalex.org/W2171167058","https://openalex.org/W2314852508","https://openalex.org/W2325614095","https://openalex.org/W2329313939","https://openalex.org/W2418836498"],"related_works":["https://openalex.org/W2091555698","https://openalex.org/W4239283910","https://openalex.org/W2589525010","https://openalex.org/W2110886272","https://openalex.org/W2000428087","https://openalex.org/W4404471222","https://openalex.org/W2037285326","https://openalex.org/W7096057963","https://openalex.org/W2042176364","https://openalex.org/W1985362631"],"abstract_inverted_index":{"Our":[0],"objective":[1],"was":[2],"to":[3,109,126,150,215],"examine":[4],"the":[5,17,22,25,102,120,207,226,252],"influence":[6],"of":[7,19,24,41,51,175,180,187,209,229,246,254],"ritonavir":[8,20,52,183,210,224,249],"on":[9,21,211],"P-glycoprotein":[10],"(P-gp)":[11],"activity":[12],"in":[13,29,89,136],"humans":[14],"by":[15,170],"characterizing":[16],"effect":[18,208],"pharmacokinetics":[23,213,253],"P-gp":[26,259],"substrate":[27],"digoxin":[28,42,59,103,161,181,212],"individuals":[30],"with":[31],"known":[32],"MDR1":[33,82,220],"genotypes.":[34,221],"Healthy":[35],"volunteers":[36],"received":[37],"a":[38],"single":[39],"dose":[40,60],"0.4":[43],"mg":[44,54],"orally":[45],"before":[46],"and":[47,62,69,87,92,119,197],"after":[48,182],"14":[49],"days":[50],"200":[53],"twice":[55],"daily.":[56],"After":[57],"each":[58],"blood":[61],"urine":[63],"were":[64,77,95,168,189],"collected":[65],"over":[66],"72":[67],"hours":[68],"analyzed":[70],"for":[71,240],"digoxin.":[72],"Digoxin":[73,139],"pharmacokinetic":[74,162],"parameter":[75,163],"values":[76],"determined":[78,96],"using":[79,97],"noncompartmental":[80],"methods.":[81],"genotypes":[83],"at":[84,191],"positions":[85],"3435":[86,193],"2677":[88,199],"exons":[90],"26":[91],"21,":[93],"respectively,":[94],"PCR-RFLP":[98],"analysis.":[99],"Ritonavir":[100],"increased":[101],"AUC(0-72)":[104],"from":[105,122,143],"26.20":[106],"+/-":[107,111,124,128,145,152],"8.67":[108],"31.96":[110],"11.24":[112],"ng":[113,130],"x":[114,131,148,155],"h/mL":[115,132],"(P":[116,133,157],"=":[117,134,158],"0.03)":[118],"AUC(0-8)":[121],"6.25":[123],"1.8":[125],"8.04":[127],"2.22":[129],"0.02)":[135],"12":[137],"subjects.":[138],"oral":[140],"clearance":[141,228],"decreased":[142],"149":[144],"101":[146],"mL/h":[147,154],"kg":[149,156],"105":[151],"57":[153],"0.04).":[159],"Other":[160],"values,":[164],"including":[165],"renal":[166],"clearance,":[167],"unaffected":[169],"ritonavir.":[171],"Overall,":[172],"75%":[173],"(9/12)":[174],"subjects":[176,188],"had":[177],"higher":[178],"concentrations":[179],"administration.":[184],"The":[185,236],"majority":[186],"heterozygous":[190],"position":[192,198],"(C/T)":[194],"(6":[195],"subjects)":[196],"(G/T,A)":[200],"(7":[201],"subjects);":[202],"although":[203],"data":[204],"are":[205,258],"limited,":[206],"appears":[214],"occur":[216],"across":[217],"all":[218],"tested":[219],"Concomitant":[222],"low-dose":[223],"reduced":[225],"nonrenal":[227],"digoxin,":[230],"thereby":[231],"increasing":[232],"its":[233],"systemic":[234],"availability.":[235],"most":[237],"likely":[238],"mechanism":[239],"this":[241],"interaction":[242],"is":[243],"ritonavir-associated":[244],"inhibition":[245],"P-gp.":[247],"Thus,":[248],"can":[250],"alter":[251],"coadministered":[255],"medications":[256],"that":[257],"substrates.":[260]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":4},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":2},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}